InMode (INMD) FCF Payout Ratio (2018 - 2026)

InMode (INMD) posted FCF Payout Ratio of 25.34 for Q1 2026, up 146.98% sequentially from 10.26 in Q3 2025, and up 145.35% YoY from 10.33 in Q1 2025.

InMode (INMD) FCF Payout Ratio (2018 - 2026) Analysis & Trends

InMode has reported FCF Payout Ratio for 9 years, with the latest figure at 25.34 in Q1 2026.

Quarterly FCF Payout Ratio rose 145.35% year-over-year to 25.34 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.51 (up 170.84% YoY) and the FY2023 annual result came in at 0.82, up 51.32% from the prior year.
FCF Payout Ratio advanced to 25.34 in Q1 2026 per INMD's latest filing, from 10.26 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 25.34 in Q1 2026 and troughed at 1.39 in Q1 2022.
A 5-year average of 5.76 and a median of 3.22 in 2023 frame the typical range for FCF Payout Ratio.
The sharpest annual moves came in 2022 and 2025: FCF Payout Ratio slumped 46.63% in 2022, then surged 309.36% in 2025.
Over 5 years, FCF Payout Ratio stood at 1.7 in 2022, then jumped by 39.08% to 2.36 in 2023, then soared by 104.66% to 4.83 in 2024, then surged by 112.44% to 10.26 in 2025, then surged by 146.98% to 25.34 in 2026.
According to Business Quant data, FCF Payout Ratio over the past three periods registered 25.34, 10.26, and 8.9 for Q1 2026, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	0.55
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	0.32
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	0.44
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	-
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	0.24
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	-0.73
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	0.22
10	InMode	911.60 Mn	496.43 Mn	71.52 Mn	18.63

Download Data